alpha 1 antitrypsin therapy (Cloud Pharmaceuticals)

N/A

Report date: 2025/03/14 16:50:24
NME

Base Information

Drug Namealpha 1 antitrypsin therapy (Cloud Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1-antiproteinase modulators
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsEmphysemaalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCloud Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCloud Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEmphysemaalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A